Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants
Description
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest healthcare issue worldwide. This study aimed to develop a monoclonal antibody against SARS-CoV-2 from B cells of recovered COVID-19 patients, which